...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

hummmmm,,,, well,,,,,I assume any entity out there has to have a source where these shares can actually be attained if a buyout or other was to happen. Who supplies these shares if such were to happen?,,,, I will assume if you are not registered in Computershare as owning the shares bought OTC you would be $hit out of luck,,,,,thats my guess,,,,the trading is sort of like dealing in crypto shares imo.

Share
New Message
Please login to post a reply